Sectors

Blood test provider Lumos Diagnostics secured $17.9m and aims to go public in a 2021 IPO that would provide an exit for series A lead investor Planet Innovation.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

MIT's cancer therapy developer has set terms for an offering that will raise more than $185m if it floats at the top of its range.

10x Genomics has bought Harvard's genetic sequencing system provider and also revealed it closed its purchase of Stockholm University spinout CartaNA.

HPE joined existing investors CapitalG and Broadridge in a round that hiked the no-code app software developer's valuation to the $2bn mark.

The GV-backed health insurance provider has agreed to merge with a special purpose acquisition company in a deal that will value it at $3.7bn.

GV is in line for an exit as the cancer therapy developer set terms for an offering that will raise more than $185m if it floats at the top of its range.

The customer support and phone contact platform developer increased its valuation to $1.2bn in a GV-backed round that took its total funding to $220m.

MAmit Sridharan has departed from his corporate venturing role at Mahindra Group to set up First Rays Venture Partners, which will work with CVCs in deals.

University of Florida's $1m seed fund backed four university spinouts in its inaugural year in sectors including industrial and healthcare.

The unit's second Impact Fund is double the size of the first vehicle, which it launched three years ago to tackle social, environmental and inclusion issues.